In two years, the amount of lab space in Greater Boston has ballooned by 57 percent, according to research from real estate brokerage firm Colliers. In 2021, biopharma companies in Massachusetts received a staggering $13.7 billion in venture capital funding, up 70 percent from 2020. Somerville alone approved more than 600,000 square feet of life-science projects, and has 2 million more square feet due to come online within the next year.